despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. .
about .
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
.
OFF DEAL
OFF DEAL
OFF DEAL